Delegations were offered COVID-19 vaccines at the tournament ©FIBA

The International Basketball Federation (FIBA) has confirmed all delegations were offered a COVID-19 vaccine at the Women’s AmeriCup in Puerto Rico.

The governing body said the offer highlighted efforts to ensure safety of all its members during the pandemic.

Delegations from Argentina, Brazil, Canada, Colombia, El Salvador, United States, Virgin Islands, Puerto Rico, Dominican Republic and Venezuela were offered the Janssen vaccine.

FIBA said players, coaches, members of the technical staff, referees and its staff were among those eligible.

Around 300 members of the FIBA AmeriCup bubble in San Juan were able to receive the vaccine.

FIBA said this was possible due to a collaboration between the governing body's regional office in the Americas, the Puerto Rican Basketball Federation (FBPUR) and the Puerto Rico Department of Health.

The vaccine, developed by Johnson & Johnson's pharmaceutical arm Janssen, is administered in a single dose.

This meant participants able to receive the dose at the competition returned to their nations fully vaccinated.

FIBA said it will continue to implement new ways to provide a safe return to normalcy and basketball.

The United States won the tournament, which concluded on Saturday (June 19).

The US team overcame hosts Puerto Rico 74-59 in the final at Coliseo Roberto Clemente.

Brazil took the bronze medal after defeating Canada 87-82 in double overtime.

The tournament had been impacted by COVID-19, with Argentina eliminated in the group stage after having to forfeit two of their matches due to positive cases among their team.